| Description | α-Hydroxyglutaric Acid Lithium, converted from glutamate in microorganisms and animals, is an inhibitor of α-ketoglutarate-dependent dioxygenase and 5-methylcytosine hydroxylase, and has an inhibitory effect on ATP synthase and mTOR signaling. |
| In vitro | α-Hydroxyglutaric Acid Lithium inhibits the activity of multiple histone demethylases. In the active site of histone demethylases, α-Hydroxyglutaric Acid Lithium occupies the same space as α-KG, leading to inhibition of their activity. Additionally, α-Hydroxyglutaric Acid Lithium inhibits the activity of TET 5-methylcytosine hydroxylases[1].Treatment of U-87MG cells with α-Hydroxyglutaric Acid Lithium at concentrations ranging from 10 to 50 mM results in increased levels of HIF-1α and decreased levels of endostatin[1]. |
| Synonyms | α-Hydroxyglutaric Acid Lithium(2889-31-8 Free base) |
| molecular weight | 159.98 |
| Molecular formula | C5H6Li2O5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 1mg/ml, Sonication is recommended. |
| References | 1. Wei Xu, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011 Jan 18;19(1):17-30. |